Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis
Xinhua Chen, Zhiyuan Chen, Andrew S. Azman, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 5, pp. e598-e609
Open Access | Times Cited: 239

Showing 1-25 of 239 citing articles:

Nurses' burnout and associated risk factors during the COVID‐19 pandemic: A systematic review and meta‐analysis
Petros Galanis, Irène Vraka, Despoina Fragkou, et al.
Journal of Advanced Nursing (2021) Vol. 77, Iss. 8, pp. 3286-3302
Open Access | Times Cited: 766
Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection
Seyed Hamid Safiabadi Tali, Jason J. LeBlanc, Zubi Sadiq, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 3
Open Access | Times Cited: 350
Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis
Ryan M Barber, Reed J D Sorensen, David M. Pigott, et al.
The Lancet (2022) Vol. 399, Iss. 10344, pp. 2351-2380
Open Access | Times Cited: 257
Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis
Niklas Bobrovitz, Rahul K. Arora, Christian Cao, et al.
PLoS ONE (2021) Vol. 16, Iss. 6, pp. e0252617-e0252617
Open Access | Times Cited: 239
Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies
Isabel Bergeri, Mairead Whelan, Harriet Ware, et al.
PLoS Medicine (2022) Vol. 19, Iss. 11, pp. e1004107-e1004107
Open Access | Times Cited: 216
Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study
Wei Wang, Qianhui Wu, Juan Yang, et al.
BMJ (2020), pp. m4704-m4704
Open Access | Times Cited: 184
Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications
Andrew Levin, Nana Owusu‐Boaitey, Sierra Pugh, et al.
BMJ Global Health (2022) Vol. 7, Iss. 5, pp. e008477-e008477
Open Access | Times Cited: 166
Controlling the pandemic during the SARS-CoV-2 vaccination rollout
João Viana, Christiaan H. van Dorp, Ana Nunes, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 128
SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021
Hannah C. Lewis, Harriet Ware, Mairead Whelan, et al.
BMJ Global Health (2022) Vol. 7, Iss. 8, pp. e008793-e008793
Open Access | Times Cited: 126
Reconciling estimates of global spread and infection fatality rates of COVID‐19: An overview of systematic evaluations
John P. A. Ioannidis
European Journal of Clinical Investigation (2021) Vol. 51, Iss. 5
Open Access | Times Cited: 124
Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study
Thiago Cerqueira‐Silva, Jason R. Andrews, Viviane Boaventura, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 6, pp. 791-801
Open Access | Times Cited: 123
SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021
Manoj Murhekar, Tarun Bhatnagar, Jeromie Wesley Vivian Thangaraj, et al.
International Journal of Infectious Diseases (2021) Vol. 108, pp. 145-155
Open Access | Times Cited: 121
Despite vaccination, China needs non-pharmaceutical interventions to prevent widespread outbreaks of COVID-19 in 2021
Juan Yang, Valentina Marziano, Xiaowei Deng, et al.
Nature Human Behaviour (2021) Vol. 5, Iss. 8, pp. 1009-1020
Open Access | Times Cited: 111
Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial
Dean Follmann, Holly Janes, Olive D. Buhule, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 9, pp. 1258-1265
Open Access | Times Cited: 110
SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020–March 2021
Jackie Kleynhans, Stefano Tempia, Nicole Wolter, et al.
Emerging infectious diseases (2021) Vol. 27, Iss. 12, pp. 3020-3029
Open Access | Times Cited: 96
The success of SARS-CoV-2 vaccines and challenges ahead
Kanta Subbarao
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1111-1123
Open Access | Times Cited: 90
Pediatric and Parents' Attitudes Towards COVID-19 Vaccines and Intention to Vaccinate for Children
Soo‐Han Choi, Yoon Hee Jo, Kyo Jin Jo, et al.
Journal of Korean Medical Science (2021) Vol. 36, Iss. 31
Open Access | Times Cited: 83
Seroprevalence of anti‐SARS‐CoV‐2 antibodies in Africa: A systematic review and meta‐analysis
Master Chisale, Sheena Ramazanu, Saul Eric Mwale, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 2
Open Access | Times Cited: 80
Update on SARS-CoV-2 seroprevalence: regional and worldwide
Ali Rostami, Mahdi Sepidarkish, Aylar Fazlzadeh, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 12, pp. 1762-1771
Open Access | Times Cited: 70
Infection fatality rate of COVID-19 in community-dwelling elderly populations
Cathrine Axfors, John P. A. Ioannidis
European Journal of Epidemiology (2022) Vol. 37, Iss. 3, pp. 235-249
Open Access | Times Cited: 55
SARS-CoV-2 seroprevalence in children worldwide: a systematic review and meta-analysis
Reza Naeimi, Mahdi Sepidarkish, Abolfazl Mollalo, et al.
EClinicalMedicine (2022) Vol. 56, pp. 101786-101786
Open Access | Times Cited: 54
Diagnostics and analysis of SARS-CoV-2: current status, recent advances, challenges and perspectives
Tao Dong, Mingyang Wang, Junchong Liu, et al.
Chemical Science (2023) Vol. 14, Iss. 23, pp. 6149-6206
Open Access | Times Cited: 38
Adherence to mask-wearing and its impact on the incidence and deaths of viral respiratory infectious diseases: a systematic review, meta-analysis and modelling study
Can Chen, Wenkai Zhou, Jiaxing Qi, et al.
BMJ Global Health (2025) Vol. 10, Iss. 2, pp. e017087-e017087
Open Access | Times Cited: 1
Serology- and PCR-based cumulative incidence of SARS-CoV-2 infection in adults in a successfully contained early hotspot (CoMoLo study), Germany, May to June 2020
Claudia Santos-Hövener, Hannelore Neuhauser, Angelika Schaffrath Rosario, et al.
Eurosurveillance (2020) Vol. 25, Iss. 47
Open Access | Times Cited: 58
SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon
Kenechukwu Obumneme Samuel Nwosu, Joseph Fokam, Franck Wanda, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 53
Page 1 - Next Page

Scroll to top